Teva Pharmaceutical Industries Limited (TEVA) 은(는) 상장 기업입니다 헬스케어 섹터의 Drug Manufacturers - Specialty & Generic 산업에서 운영. 본사 소재지는 Tel Aviv, Israel. 현재 CEO는 Richard D. Francis.
TEVA 을(를) 보유 IPO 날짜 1982-02-16, 37,000 명의 정규직 직원, 에 상장 NYSE, 시가총액 $36.99B.
Teva Pharmaceutical Industries Limited is a global pharmaceutical company headquartered in Tel Aviv, Israel, that develops, manufactures, and distributes generic medicines, specialty medicines, and biopharmaceutical products across North America, Europe, and international markets. The company operates across multiple therapeutic areas including central nervous system, pain, respiratory, and oncology, offering products in diverse dosage forms such as tablets, injectables, inhalants, and transdermal patches. Its portfolio includes well-known brands such as Copaxone for multiple sclerosis, AJOVY for migraine prevention, and AUSTEDO for movement disorders, alongside respiratory treatments including ProAir and QVAR for asthma and COPD, and oncology products such as Treanda and Granix. Teva also manufactures active pharmaceutical ingredients and collaborates with partners like MedinCell to develop long-acting injectable formulations. Founded in 1901, the company has established itself as a major player in the global pharmaceutical industry.
